Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

specific

A follicular helper T-cell lymphoma, angioimmunoblastic-type that is resistant to treatment.

15

Centers

15

Active Trials

—

Cancer Funding

Top Centers for Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
53.3
2
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
53.3
3
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
Active Research Program
53.3
4
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
53.3
5
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
53.3
6
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
53.3
7
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
53.3
8
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
53.3
9
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
Active Research Program
53.3
10
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
53.3
11
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
53.3
12
University of Illinois Cancer CenterChicago, IL
Active Research Program
53.3
13
Cancer Center at IllinoisUrbana, IL
Active Research Program
53.3
14
Princess Margaret Cancer CentreToronto, ON
Active Research Program
53.3
15
BC CancerVancouver, BC
Active Research Program
53.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →